SPARC gets US FDA approval for Epilepsy Drug Keppra XR Generic

11 Sep 2013 Evaluate

Sun Pharma Advanced Research Company (SPARC) has received US FDA (Food and Drug Administration) approval for Epilepsy Drug Keppra XR Generic. Keppra is an anti-epileptic drug used to treat partial onset seizures in people with epilepsy. Keppra is also used to treat tonic-clonic seizures in adults and children who are at least 6 years old, and myoclonic seizures in adults and children who are at least 12 years old. Keppra may also be used for purposes not listed in this medication guide.

SPARC is an international pharmaceutical company engaged in research and development of drugs and delivery systems.

Sun Pharma Adv. Res Share Price

133.75 -0.30 (-0.22%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 654.25
Indegene 522.50
CMS Info Systems 343.20
Sagility 52.23
Smartworks Coworking 472.85
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×